Migraine Miracle Jab 'Could Be Approved By NHS In New Year'

0
112

Millions of people are set to benefit from the first new migraine drug in 20 years, a landmark study revealed last night.The monthly injection, called erenumab, prevents nearly half of migraine attacks for people who have few other treatment options, scientists found.The medication, developed by UK scientists over the last three decades, has been submitted for a medical licence in Europe and the US and will be assessed by NHS watchdog NICE in May.

More than eight million Britons – three quarters of them women – suffer migraine attacks, which involve dizziness, nausea and headaches.Attacks can last anything from four to 72 hours.The problem affects more people than diabetes, asthma and epilepsy combined – and is the sixth most common cause of disability in the world.Yet until now there has been no treatment specifically designed to prevent the problem, with patients instead given beta blockers, antidepressants and botox in a bid to stave off the crippling attacks.

LEAVE A REPLY

Please enter your comment!
Please enter your name here